Zhang, W., Fulci, G., Buhrman, J. S., Stemmer-Rachamimov, A. O., Chen, J. W., Wojtkiewicz, G. R., . . . Martuza, R. L. (2012). Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma. Nature Publishing Group.

Zhang, Wei, Giulia Fulci, Jason S. Buhrman, Anat O. Stemmer-Rachamimov, John W. Chen, Gregory R. Wojtkiewicz, Ralph Weissleder, Samuel D. Rabkin, a Robert L. Martuza. Bevacizumab With Angiostatin-armed OHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma. Nature Publishing Group, 2012.

Zhang, Wei, et al. Bevacizumab With Angiostatin-armed OHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma. Nature Publishing Group, 2012.